Taiwan - Delayed Quote TWD

Tanvex BioPharma, Inc. (6541.TW)

53.50
-2.10
(-3.78%)
At close: 1:30:12 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-1,144,956
-1,150,599
-1,435,357
-1,333,847
-1,387,021
Investing Cash Flow
926,995
-109,254
-83,571
-97,352
-24,682
Financing Cash Flow
904,857
1,255,084
1,079,542
-123,290
1,597,317
End Cash Position
1,072,133
376,959
380,752
786,233
2,222,977
Capital Expenditure
-83,491
-110,768
-71,337
-96,079
-30,346
Issuance of Capital Stock
1,449,981
1,439,668
1,207,210
7,235
1,690,429
Issuance of Debt
2,646
377,646
0
--
0
Repayment of Debt
--
-377,646
0
--
--
Free Cash Flow
-1,228,447
-1,261,367
-1,506,694
-1,429,926
-1,417,367
12/31/2021 - 8/13/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers